<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Select neoplastic causes of ovarian mass in children and adolescents&lt;sup&gt;[1-3]&lt;/sup&gt;</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Select neoplastic causes of ovarian mass in children and adolescents<sup>[1-3]</sup></h1>
<div class="graphic"><div class="figure"><div class="ttl">Select neoplastic causes of ovarian mass in children and adolescents<sup>[1-3]</sup></div><div class="cntnt"><table cellspacing="0"><colgroup span="3" width="33%"></colgroup> <tbody> <tr> <td class="subtitle1">Type of tumor</td> <td class="subtitle1">Associated clinical features</td> <td class="subtitle1">Ultrasonographic appearance</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Benign germ cell tumors</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <p>Mature cystic teratoma</p> Also called: <ul class="decimal_heading"> <li>Mature teratoma </li> <li>Dermoid cyst (dermoid) </li> <li>Benign cystic teratoma </li> </ul> </td> <td> <ul> <li>Most common ovarian neoplasm in children </li> <li>Often discovered incidentally </li> <li>20 to 25% present with abdominal pain </li> <li>May present with nausea </li> <li>Bilateral in up to 10% </li> <li>Associated with anti-NMDAR encephalitis </li> </ul> </td> <td> <ul> <li>Complex (cystic with solid components: calcification, echogenic material, fat-fluid levels) </li> <li>May contain thick sebaceous fluid, hair, and calcium </li> <li>Mean tumor size 6.5 cm </li> </ul> </td> </tr> <tr class="divider_bottom"> <td class="indent1">Gonadoblastoma</td> <td> <ul> <li>Typically associated with gonadal dysgenesis in phenotypically female patients with a Y chromosome/Y chromosome fragment (eg, Turner syndrome [45XO/46XY]) </li> <li>Bilateral in 40% </li> <li>May be associated with malignant germ cell tumor (dysgerminoma) </li> <li>Associated with disorders with mutation in the <a href="https://omim.org/entry/607102" target="_blank"><em>WT1</em> gene</a> (eg, <a href="https://omim.org/entry/136680" target="_blank">Frasier syndrome</a> and <a href="https://omim.org/entry/194080" target="_blank">Denys-Drash syndrome</a>) </li> </ul> </td> <td> <ul> <li>Solid mass with calcification </li> <li>May be too small to easily detect with ultrasonography </li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="3">Benign epithelial tumors</td> </tr> <tr class="divider_bottom"> <td class="indent1">Serous and mucinous cystadenoma</td> <td> <ul> <li>10 to 20% of ovarian tumors </li> <li>Usually diagnosed after menarche </li> </ul> </td> <td> <ul> <li>Serous: Large unilocular cystic masses without septations </li> <li>Mucinous: Multiloculated cystic mass </li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="3">Benign sex cord-stromal tumors</td> </tr> <tr class="divider_bottom"> <td class="indent1">Thecoma-fibroma</td> <td> <ul> <li>&lt;2% of ovarian tumors in children and adolescents </li> <li>Associated with ascites and pleural effusion (Meigs syndrome) </li> <li>Associated with <a href="https://omim.org/entry/109400" target="_blank">basal cell nevus syndrome</a> (Gorlin syndrome) </li> <li>May produce estrogen or testosterone </li> </ul> </td> <td> <ul> <li>Solid hypoechoic mass </li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="3">Malignant germ cell tumors</td> </tr> <tr class="divider_bottom"> <td class="indent1">Immature teratoma</td> <td> <ul> <li>Approximately 10% of complex ovarian masses in girls </li> <li>Mean age at presentation: 10 years </li> <li>Usually presents with palpable mass, but may be asymptomatic or present with abdominal pain, nausea, and/or vomiting </li> <li>Associated with gonadal dysgenesis </li> <li>May be associated with mature cystic teratoma in contralateral ovary </li> </ul> </td> <td> <ul> <li>Complex or completely solid </li> <li>May contain foci of fat and calcification </li> <li>Mean diameter 16 cm (range 5 to &gt;40 cm) </li> </ul> </td> </tr> <tr class="divider_bottom"> <td class="indent1">Dysgerminoma</td> <td> <ul> <li>Most common malignant germ cell tumor; most common ovarian malignancy in children </li> <li>Usually occurs in adolescence/early adulthood (peak incidence 15 to 19 years) </li> <li>Bilateral in approximately 15% </li> <li>Associated with gonadal dysgenesis (develops within a gonadoblastoma) </li> </ul> </td> <td> <ul> <li>Solid mass with regions of necrosis, hemorrhage, and speckled calcifications </li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="3">Malignant sex cord-stromal tumors</td> </tr> <tr class="divider_bottom"> <td class="indent1">Juvenile granulosa cell tumor</td> <td> <ul> <li>Majority of pediatric sex cord-stromal tumors </li> <li>Most occur in first or second decade </li> <li>Secrete estrogen (associated with breast enlargement and vaginal bleeding) </li> <li>Associated with menstrual irregularities </li> <li>Bilateral in &lt;5% </li> <li>Associated with <a href="https://omim.org/entry/166000" target="_blank">Ollier disease</a> and <a href="https://omim.org/entry/614569" target="_blank">Maffucci syndrome</a> </li> </ul> </td> <td> <ul> <li>Predominantly solid with cystic spaces or predominantly cystic with solid foci </li> <li>Mean tumor diameter 12.5 cm </li> </ul> </td> </tr> <tr> <td class="indent1">Sertoli-Leydig cell tumor</td> <td> <ul> <li>20% of pediatric ovarian sex cord-stromal cell tumors </li> <li>&lt;0.5% of malignant ovarian tumors in children </li> <li>Approximately 50% occur in patients 11 to 20 years and 6% in those &lt;11 years </li> <li>Most patients present with virilization or menstrual irregularities </li> <li>Associated with <a href="https://omim.org/entry/606241" target="_blank">DICER1 syndrome</a> </li> </ul> </td> <td> <ul> <li>Variable (solid, solid and cystic, predominantly cystic) </li> <li>Well-circumscribed without ascites or calcifications </li> </ul> </td> </tr> </tbody></table></div><div class="graphic_lgnd">This table is meant for use with UpToDate content related to the evaluation of ovarian masses in children and adolescents. Refer to UpToDate content for additional details. All of these tumors may be complicated by ovarian/adnexal torsion or rupture with hemorrhage.</div><div class="graphic_footnotes">NMDAR: anti-N-methyl-D-aspartate receptor.</div><div class="graphic_reference">References:

	<ol>
<li>Strickland J, Laufer M. Adnexal masses. In: Emans, Laufer, Goldstein's Pediatric and Adolescent Gynecology, 7<sup>th</sup> ed, Emans SJ, Laufer MR, Divasta AD (Eds), Wolters Kluwer, Philadelphia 2020. p.529.</li>
<li>Mahajan P, Weldon CB, Frazier AL, Laufer MR. Gynecologic cancers in children and adolescents. In: Emans, Laufer, Goldstein's Pediatric and Adolescent Gynecology, 7<sup>th</sup> ed, Emans SJ, Laufer MR, Divasta AD (Eds), Wolters Kluwer, Philadelphia 2020. p.556.</li>
<li>Lala SV, Strubel N. Ovarian neoplasms of childhood. Pediatr Radiol 2019; 49:1463.</li>
</ol></div><div id="graphicVersion">Graphic 128371 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
